News

News

  • Conozca un adaptador: Greg Merritt

    Lee este artículo en inglés. El socio del paciente de ADAPTABLE, Greg Merritt, comparte su perspectiva sobre el valor que los pacientes aportan a la investigación clínica y cómo los pacientes y los investigadores pueden trabajar juntos en la investigación y el tratamiento. “Cuando se invita a las personas a involucrarse con la investigación y a compartir ...
  • When Patients Partner with Researchers: Greg’s Perspective

    Lee este artículo en español. ADAPTABLE patient partner, Greg Merritt, shares his perspective on the value patients bring to clinical research and how patients and researchers can work together in research and treatment. “When people are invited to get involved with research and bring all their experiences, we can study a question from a truly collaborative perspective, creating ...
  • Cada participante cuenta desde la inscripción hasta completar el estudio

    Lee este artículo en inglés. En estudios de investigación como ADAPTABLE, los investigadores inicialmente se concentran en inscribir pacientes en el estudio. Todo estudio clínico tiene un número de inscripción “objetivo”, que es el número de participantes que los investigadores esperan inscribir en el estudio. Para ADAPTABLE ese número es 15,000 participantes. Alcanzar este número es ...
  • Every Participant Counts from Enrollment to Study Completion

    Lee este artículo en español. In research studies like ADAPTABLE, researchers initially focus on enrolling patients in the study.  Every clinical study has a “target” enrollment number, which is the number of participants researchers hope will enroll in the study. For ADAPTABLE that number is 15,000 participants. Reaching this number is important so that researchers can ...
  • Making Sense of it all: A Review of Recent Studies on the Role of Aspirin in Preventing Heart Disease and how ADAPTABLE fits in the Picture

    Aspirin is a drug that has been used for decades to prevent the occurrence of a heart attack or stroke by thinning blood so clots do not form. Doctors recommend either high-dose (325 mg) or low-dose (81 mg) aspirin and its use across the United States is fairly balanced between high-dose and low-dose aspirin. The ADAPTABLE ...
  • When Patients Partner with Researchers: Desiree’s Perspective

    In ADAPTABLE, patients are more than study participants, they are partners with researchers and clinicians to improve cardiovascular health for all patients and those who care for them. Adaptors are patient representatives who have been involved in ADAPTABLE from the beginning. The Adaptors team works alongside the study team, participating in team meetings and providing ...
  • Importance of Diversity in Clinical Research

    The main phases of a clinical research study include: 1) identification and recruitment of study participants, 2) data collection and monitoring, 3) analysis of study results, and 4) distribution of study findings. ADAPTABLE team members are currently focused on the first two phases. In this article, we explore why it is important that people of ...
  • Taking a Real-Time Approach to Identifying and Enrolling Patients in the ADAPTABLE Study

    The Duke Heart Center, the second highest enrolling site in the ADAPTABLE study, recently celebrated a milestone with more than 1,000 patients enrolled. In this article, the team shares how they leverage their electronic health record (EHR) system to streamline the screening process for this pragmatic study designed to answer what is the best daily ...
  • ADAPTABLE Study Team Shares Patient Engagement Experiences in CardioSmart Pavilion at American College Cardiology Conference

    Jacqueline Alikhaani, a rare disease heart patient and partner on the ADAPTABLE Study, is passionate about the value and impact of novel clinical research studies. Alikhaani is especially passionate about studies that leverage electronic health records and common data resources, and includes patient input at every critical step in the process. “One of the special ...
  • Celebrating Your Heart and February

    The ADAPTABLE Team is excited for February, a month-long celebration of heart-health awareness. This a great time to think about what is known about heart disease, how heart-healthy choices can make a difference, and the potential impact of the results from the ADAPTABLE Study for patients and their doctors. Heart Disease Heart disease is the leading cause ...

tertiary sidebar container